ArticleInternational journal of general medicine2022

Effectiveness and Tolerability of Anlotinib Plus PD-1 Inhibitors for Patients with Previously Treated Metastatic Soft-Tissue Sarcoma.

Xin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.